FDA Approves Pfizer’s Blood Cancer Therapy

Published on August 14, 2023

The U.S. Food and Drug Administration on Monday granted accelerated approval to Pfizer’s therapy for treating patients with a type of blood cancer that is difficult to treat, the company said.

Read Full Article (External Site)